GU CONNECT is an international group of experts in the field of genitourinary oncology and is an initiative of COR2ED. The group discusses the latest scientific and clinical insights, identifies educational needs, and develops educational programmes to support healthcare professionals globally to provide the best possible care to their patients.
GU CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from AstraZeneca, Bayer and Eisai Europe Limited.
What’s new from GU CONNECT
Conference update
ESMO 2024: New data on GI, lung, HCC, breast and GU cancers
Renowned medical experts share their insights into new data presented at ESMO 2024
-
Downloadable
Resources -
5 MIN
-
Sep 2024
Downloadable 
5 MIN
Sep 2024 
Video
Systemic treatment options for patients with non-clear cell renal cell carcinoma (nccRCC)
Managing patients with nccRCC: guidelines, recommendations, and best practice
Experts
Prof. Laurence AlbigesEndorsed by
-
Downloadable
Resources -
4 MIN
-
Dec 2024
Interactive patient case
Advanced renal cell carcinoma: Managing a long-term durable response
Maximising outcomes for patients with advanced RCC
Experts
Prof. Michael StaehlerEndorsed by
-
MIN
-
Jun 2024
Conference update
RCC Update from ESMO 2023
How will the latest data impact clinical practice?
Experts
Prof. Laurence Albiges-
Downloadable
Resources -
4 MIN
-
Oct 2023
Micro learning
Module
2
of 2
PARP inhibitors in prostate cancer and the rationale behind combination treatment
Module 2 - Evolving landscape of PARPi in mCRPC: Combination with anti-androgens
Experts
Assoc. Prof. Alicia Morgans, Dr Pasquale RescignoEndorsed by
-
Downloadable
Resources -
4 MIN
-
Oct 2023
Interactive patient case
Optimising treatment for advanced RCC
Journey through an interactive patient case
Experts
Prof. Viktor Grünwald-
15 MIN
-
Oct 2023